Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study
维多珠单抗和抗肿瘤坏死因子α在未接受过生物制剂治疗的炎症性肠病患者中的真实世界疗效:EVOLVE研究结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjab058
Bressler, Brian; Yarur, Andres; Silverberg, Mark S; Bassel, Marielle; Bellaguarda, Emanuelle; Fourment, Chris; Gatopoulou, Anthie; Karatzas, Pantelis; Kopylov, Uri; Michalopoulos, George; Michopoulos, Spyridon; Navaneethan, Udayakumar; Rubin, David T; Siffledeen, Jesse; Singh, Andrew; Soufleris, Konstantinos; Stein, Dara; Demuth, Dirk; Mantzaris, Gerassimos J